GALMED PHARMACEUTICALS LTD's ticker is GLMD and the CUSIP is M47238106. A total of 11 filers reported holding GALMED PHARMACEUTICALS LTD in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $5,412,000 | +17.0% | 1,563,640 | +95.5% | 0.32% | -39.7% |
| Q4 2019 | $4,624,000 | -28.7% | 800,000 | -41.0% | 0.53% | -26.6% |
| Q3 2019 | $6,483,000 | -34.7% | 1,356,356 | +0.5% | 0.72% | -20.1% |
| Q2 2019 | $9,923,000 | -10.0% | 1,350,000 | 0.0% | 0.90% | -9.8% |
| Q1 2019 | $11,030,000 | +19.6% | 1,350,000 | 0.0% | 1.00% | +78.9% |
| Q4 2018 | $9,221,000 | -49.7% | 1,350,000 | 0.0% | 0.56% | -53.0% |
| Q3 2018 | $18,333,000 | +14.1% | 1,350,000 | 0.0% | 1.19% | +9.6% |
| Q2 2018 | $16,065,000 | +344.2% | 1,350,000 | +107.9% | 1.09% | +239.4% |
| Q1 2018 | $3,617,000 | -39.1% | 649,295 | 0.0% | 0.32% | -36.1% |
| Q4 2017 | $5,941,000 | +18.3% | 649,295 | +18.2% | 0.50% | -5.1% |
| Q3 2017 | $5,021,000 | +61.9% | 549,295 | +9.9% | 0.53% | +15.5% |
| Q2 2017 | $3,101,000 | +26.8% | 500,000 | 0.0% | 0.46% | +20.3% |
| Q1 2017 | $2,445,000 | +60.3% | 500,000 | +15.1% | 0.38% | +248.6% |
| Q4 2016 | $1,525,000 | +8.7% | 434,380 | +37.5% | 0.11% | -26.8% |
| Q3 2016 | $1,403,000 | +80.1% | 316,016 | +82.1% | 0.15% | +20.2% |
| Q2 2016 | $779,000 | -40.3% | 173,516 | -34.4% | 0.12% | -46.8% |
| Q1 2016 | $1,304,000 | -35.3% | 264,600 | 0.0% | 0.23% | -15.6% |
| Q4 2015 | $2,014,000 | +2.4% | 264,600 | 0.0% | 0.28% | -4.5% |
| Q3 2015 | $1,966,000 | -26.1% | 264,600 | 0.0% | 0.29% | -47.6% |
| Q2 2015 | $2,662,000 | +6.8% | 264,600 | 0.0% | 0.55% | -41.8% |
| Q1 2015 | $2,493,000 | +60.4% | 264,600 | -1.3% | 0.95% | +39.4% |
| Q4 2014 | $1,554,000 | -27.4% | 268,000 | +7.7% | 0.68% | -6.7% |
| Q3 2014 | $2,140,000 | -17.0% | 248,800 | -6.0% | 0.73% | -25.1% |
| Q2 2014 | $2,577,000 | +41.5% | 264,546 | +66.7% | 0.97% | +37.4% |
| Q1 2014 | $1,821,000 | – | 158,735 | – | 0.71% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|